Comparison of an Interscalene Nerve Block With or Without Stellate Ganglion Block for Shoulder Surgery

Antwerp University Hospital (UZA)

Status and phase: Completed; Phase 4

Conditions: Anesthesia, Regional

Treatments: Drug: NaCl 0.9%; Drug: Levobupivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT02879916

11/20/162

B300201111454 (Registry Identifier)

Details and patient eligibility

About

This study describes the difference of analgesic effect of levobupivacaine 0.5% administered through an interscalene nerve block with or without a stellate ganglion block. The length of the analgesic effect is our primary outcome parameter. Half of the recruited patients will receive a stellate ganglion block and half of the patients won't.

Enrollment: 30 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA class 1 to 3
• Need for shoulder surgery

Exclusion criteria

• Mental retardation
• allergy for local anesthetics
• a medical reason as a contra-indication for NSAID use
• Diabetes mellitus
• peripheral neuropathy
• chronic analgetic use
• chronic pain patients

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

30 participants in 2 patient groups, including a placebo group

Placebo

Placebo Comparator group

Description:

NaCl 0.9% 3ml perineural stellate ganglion injection

Treatment:

Drug: NaCl 0.9%

Stellate ganglion block

Active Comparator group

Description:

Levobupivacaine 3ml perineural stellate ganglion injection

Treatment:

Drug: Levobupivacaine